CDK inhibition and cancer therapy.

The cell-division cycle is a tightly controlled process that is regulated by the cyclin/CDK family of protein kinase complexes. Stringent control of this process is essential to ensure that DNA synthesis and subsequent mitotic division are accurately and coordinately executed. There is now strong evidence that CDKs, their regulators, and substrates are the targets of genetic alteration in many human cancers. As a result of this, the CDKs have been targeted for drug discovery and a number of small molecule inhibitors of CDKs have been identified.

[1]  S. Steinberg,et al.  Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Sausville,et al.  UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. , 1996, Journal of the National Cancer Institute.

[3]  S H Kim,et al.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.

[4]  G. Cooper,et al.  Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1 , 1997, Molecular and cellular biology.

[5]  M. Monden,et al.  Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. , 1998, International journal of oncology.

[6]  L. Meijer,et al.  Cyclic activation of histone H1 kinase during sea urchin egg mitotic divisions. , 1988, Experimental cell research.

[7]  E. Sausville,et al.  Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. , 1996, Cancer research.

[8]  The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. , 1997, Molecular biology of the cell.

[9]  D. Morgan,et al.  Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells , 1996, The Journal of cell biology.

[10]  P. Guerrier,et al.  6-Dimethylaminopurine blocks starfish oocyte maturation by inhibiting a relevant protein kinase activity. , 1988, Experimental cell research.

[11]  David S. Park,et al.  Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress , 1998, The Journal of Neuroscience.

[12]  R. Fåhraeus,et al.  Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide from p16CDKN2/INK4A , 1996, Current Biology.

[13]  Amanda G Paulovich,et al.  When Checkpoints Fail , 1997, Cell.

[14]  David S. Park,et al.  Cyclin Dependent Kinase Inhibitors and Dominant Negative Cyclin Dependent Kinase 4 and 6 Promote Survival of NGF-Deprived Sympathetic Neurons , 1997, The Journal of Neuroscience.

[15]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[16]  E. Sausville,et al.  Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. , 1996, International journal of oncology.

[17]  James M. Roberts,et al.  Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. , 1998, Molecular cell.

[18]  E. Schierenberg,et al.  Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinases , 1995, Biology of the cell.

[19]  B. Cheson,et al.  Clinical trials referral resource. Clinical trials of flavopiridol. , 1998, Oncology.

[20]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[21]  K. W. Kim,et al.  Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. , 1998, European journal of biochemistry.

[22]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.

[23]  T. Misteli,et al.  Mitotic disassembly of the Golgi apparatus in vivo. , 1995, Journal of cell science.

[24]  J. Roth,et al.  Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. , 1995, Cancer research.

[25]  Marc W. Kirschner,et al.  How Proteolysis Drives the Cell Cycle , 1996, Science.

[26]  L. Meijer,et al.  Chemical inhibitors of cyclin-dependent kinases. , 1996, Trends in cell biology.

[27]  E. Lees.  Cyclin dependent kinase regulation. , 1995, Current opinion in cell biology.

[28]  M. Aoki,et al.  Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide , 1997, Nature Medicine.

[29]  James M. Roberts,et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.

[30]  M. Kitagawa,et al.  A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. , 1994, Oncogene.

[31]  L. Meijer,et al.  The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. , 1997, Experimental cell research.

[32]  T. Hunter,et al.  The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. , 1997, Cancer research.

[33]  P. Seth,et al.  Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. , 1997, Cancer research.

[34]  K. Nasmyth.  At the heart of the budding yeast cell cycle. , 1996, Trends in genetics : TIG.

[35]  R. Bernards,et al.  Communication between the extracellular environment, cytoplasmic signalling cascades and the nuclear cell‐cycle machinery , 1997, FEBS letters.

[36]  M. Korc,et al.  Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. , 1998, The Journal of clinical investigation.

[37]  Kenneth Cowan,et al.  A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells , 1997, Oncogene.

[38]  D. Warburton,et al.  Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[39]  F. H. Espinoza,et al.  Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases. , 1998, The cancer journal from Scientific American.

[40]  F. Sarkar,et al.  Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. , 1998, Cancer gene therapy.

[41]  M. R. Hellmich,et al.  Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. , 1997, Surgery.

[42]  S. Wang,et al.  The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. , 1998, Human pathology.

[43]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[44]  E. Sausville,et al.  Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol , 1998 .

[45]  S. Elledge,et al.  The role of Cdk7 in CAK function, a retro-retrospective. , 1998, Genes & development.

[46]  M. Grever,et al.  Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[48]  G. Peters,et al.  Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.

[49]  E. Sausville,et al.  UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase* , 1998, The Journal of Biological Chemistry.

[50]  A. Hershko.  Roles of ubiquitin-mediated proteolysis in cell cycle control. , 1997, Current opinion in cell biology.

[51]  M. Gorospe,et al.  p27Kip1 overexpression causes apoptotic death of mammalian cells , 1997, Oncogene.

[52]  E. Shooter,et al.  Apoptosis of Central and Peripheral Neurons Can Be Prevented with Cyclin‐Dependent Kinase/Mitogen‐Activated Protein Kinase Inhibitors , 1998, Journal of neurochemistry.

[53]  S. Morris.  Molecular clocks: Defusing the Cambrian ‘explosion’? , 1997, Current Biology.

[54]  T. Liu,et al.  Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers , 1997 .

[55]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[56]  M. Pagano,et al.  The ubiquitin-mediated proteolytic pathway as a therapeutic area , 1997, Journal of Molecular Medicine.

[57]  L. Rebhun,et al.  Cleavage inhibition in marine eggs by puromycin and 6-dimethylaminopurine. , 1973, Experimental cell research.

[58]  R. Weinberg,et al.  How cancer arises. , 1996, Scientific American.

[59]  O'Connor Pm.  Mammalian G1 and G2 phase checkpoints. , 1997 .

[60]  S. Kaufmann,et al.  Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. , 1996, Cancer research.

[61]  R. Fåhraeus,et al.  Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule , 1998, Oncogene.

[62]  Jianxiang,et al.  In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. , 1995, Cancer research.

[63]  W. Yung,et al.  Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro , 1997, Oncogene.

[64]  McPherson Jp,et al.  Induction of Apoptosis by Deregulated Expression of DNA Topoisomerase IIα , 1998 .

[65]  M. Kirschner,et al.  Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  D. Morgan,et al.  Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage , 1998, The Journal of cell biology.

[67]  M. Strnad,et al.  Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine. , 1997, Anti-cancer drugs.

[68]  S H Kim,et al.  Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Harris,et al.  Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage. , 1995, Journal of cell science.

[70]  N. Saijo,et al.  Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. , 1996, Anticancer research.

[71]  K Nasmyth,et al.  Viewpoint: Putting the Cell Cycle in Order , 1996, Science.

[72]  M. Shuford,et al.  Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells. , 1996, Oncogene.

[73]  R. Schlegel,et al.  Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases (*) , 1996, The Journal of Biological Chemistry.

[74]  Prem Seth,et al.  Cleavage of CDK Inhibitor p21Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[75]  G. Borasio,et al.  Survival-Promoting Activity of Inhibitors of Cyclin-Dependent Kinases on Primary Neurons Correlates with Inhibition of c-Jun Kinase-1 , 1997, Neurobiology of Disease.

[76]  Yoshio Masui,et al.  Understanding the cell cycle , 1998, Nature Medicine.

[77]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.

[78]  M. Kitagawa,et al.  Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. , 1993, Oncogene.

[79]  L Meijer,et al.  Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine , 1995, Proteins.

[80]  Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 , 1997, Current Biology.

[81]  F. Sarkar,et al.  Inhibition of Pancreatic Tumor Cell Growth in Culture by p21WEF1 Recombinant Adenovirus , 1998, Pancreas.

[82]  A Joly,et al.  CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation* , 1997, The Journal of Biological Chemistry.

[83]  P. O'Connor,et al.  DNA damage checkpoints: implications for cancer therapy. , 1996, Progress in cell cycle research.

[84]  A. Okuyama,et al.  An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. , 1998, Anticancer research.

[85]  Stephen J. Elledge,et al.  Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.

[86]  E. Sugikawa,et al.  Inhibition of p53 Protein Phosphorylation by 9‐Hydroxyellipticine: A Possible Anticancer Mechanism , 1995, Japanese journal of cancer research : Gann.

[87]  Yanping,et al.  Loss of the Cyclin-dependent Kinase Inhibitor 27Kq Protein in Human Prostate Cancer Correlates with Tumor Grade’ , 2005 .

[88]  N. Altorki,et al.  Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[89]  S. van den Heuvel,et al.  Distinct roles for cyclin-dependent kinases in cell cycle control. , 1993, Science.

[90]  L. Meijer,et al.  Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. , 1997, Journal of medicinal chemistry.

[91]  M. Loda,et al.  Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. , 1998, The American journal of pathology.

[92]  R. Kratzke,et al.  Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression , 1998, Oncogene.

[93]  E. Nabel,et al.  The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo , 1995, Nature Medicine.

[94]  K. A. McKenna,et al.  Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases. , 1996, Cancer research.

[95]  E. Sausville,et al.  Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. , 1998, The Journal of clinical investigation.

[96]  J. Bruner,et al.  Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. , 1996, Oncogene.

[97]  P. Greengard,et al.  Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Broggini,et al.  p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. , 1997, Cancer research.

[99]  J. Blow,et al.  Inhibition of cyclin-dependent kinases by purine analogues. , 1994, European journal of biochemistry.

[100]  S H Kim,et al.  Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. , 1997, European journal of biochemistry.

[101]  James M. Roberts,et al.  Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.

[102]  J. Pouysségur,et al.  A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. , 1996, Progress in cell cycle research.

[103]  E. Sausville,et al.  Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. , 1992, Journal of the National Cancer Institute.

[104]  S. Moreno,et al.  Regulation of CDK/cyclin complexes during the cell cycle. , 1997, The international journal of biochemistry & cell biology.

[105]  G. Peters,et al.  Features of replicative senescence induced by direct addition of antennapedia‐p16INK4A fusion protein to human diploid fibroblasts , 1998, FEBS letters.

[106]  Roger Brent,et al.  Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 , 1996, Nature.

[107]  J. Bartek,et al.  Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death , 1997, Nature Medicine.

[108]  D. Schiffer,et al.  p27/kip1 expression in human astrocytic gliomas , 1997, Neuroscience Letters.

[109]  V. Rialet,et al.  A new screening test for antimitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates. , 1991, Anticancer research.

[110]  P. Seth,et al.  Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[111]  Y. Doki,et al.  Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. , 1997, Cancer research.